Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Taurine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.74 |
| ▸ | BLM | P54132 | 2/20 | 0.74 |
| ▸ | SLC6A6 | P31641 | 1/20 | 0.74 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.74 |
| ▸ | APP | P05067 | 1/20 | 0.52 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.38 |
| ▸ | PDE4A | P27815 | 1/20 | 0.38 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.37 |
| ▸ | LCK | P06239 | 1/20 | 0.37 |
| ▸ | FYN | P06241 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | PAOX | Q6QHF9 | 4/20 | 0.33 |
| ▸ | GABRR1 | P24046 | 3/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.32 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.32 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.32 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Taurine SCHEMBL3152449 | 1.00 | LMNA (0.74) | LMNABLMSLC6A6CYP2C19APP | |
| Taurine SCHEMBL21051780 | 0.90 | LMNA (0.67) | LMNABLMSLC6A6CYP2C19APP | |
| Taurine SCHEMBL4449607 | 0.89 | LMNA (0.82) | LMNABLMSLC6A6CYP2C19APP | |
| Taurine SCHEMBL27814625 | 0.86 | LMNA (0.78) | LMNABLMSLC6A6CYP2C19APP | |
| Taurine SCHEMBL28062289 | 0.86 | LMNA (0.61) | LMNABLMSLC6A6CYP2C19APP | |
| Taurine SCHEMBL29931159 | 0.86 | — | — | |
| Taurine SCHEMBL28148201 | 0.86 | — | — | |
| Taurine SCHEMBL23068 | 0.86 | — | — | |
| Taurine SCHEMBL30179154 | 0.86 | — | — | |
| Taurine SCHEMBL30191395 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11015152-B2 | Cleansing bars with taurine | COLGATE-PALMOLIVE COMPANY (US) | 2021-05-25 | — | — | US | claimed |
| CN-108713054-B | Cleansing bar containing taurine | 高露洁-棕榄公司 | 2020-09-29 | — | — | CN | claimed |
| EP-3383984-B1 | CLEANSING BARS WITH TAURINE | COLGATE PALMOLIVE CO (US) | 2020-03-11 | — | — | EP | claimed |
| EP-3220879-B1 | CLEANSING BARS WITH TAURINE | COLGATE PALMOLIVE CO (US) | 2020-03-04 | — | — | EP | claimed |
| CN-107001999-B | Cleansing bar containing taurine | 高露洁-棕榄公司 | 2020-02-07 | — | — | CN | claimed |
| US-10400199-B2 | Cleansing bars with taurine | COLGATE-PALMOLIVE COMPANY (US) | 2019-09-03 | — | — | US | claimed |
| US-20180355293-A1 | Cleansing Bars with Taurine | COLGATE-PALMOLIVE COMPANY (US) | 2018-12-13 | — | — | US | claimed |
| CN-108713054-A | Cleansing bars containing taurine | 高露洁-棕榄公司 | 2018-10-26 | — | — | CN | claimed |
| EP-3383984-A1 | CLEANSING BARS WITH TAURINE | Colgate-Palmolive Company (US) | 2018-10-10 | — | — | EP | claimed |
| US-20170335251-A1 | Cleansing Bars with Taurine | COLGATE-PALMOLIVE COMPANY (US) | 2017-11-23 | — | — | US | claimed |
| EP-3220879-A1 | CLEANSING BARS WITH TAURINE | Colgate-Palmolive Company (US) | 2017-09-27 | — | — | EP | claimed |
| CN-107001999-A | Cleansing bar containing taurine | 高露洁-棕榄公司 | 2017-08-01 | — | — | CN | claimed |
| WO-2017095445-A1 | CLEANSING BARS WITH TAURINE | COLGATE-PALMOLIVE COMPANY (US) | 2017-06-08 | — | — | WO | claimed |
| WO-2016089422-A1 | CLEANSING BARS WITH TAURINE | COLGATE-PALMOLIVE COMPANY (US) | 2016-06-09 | — | — | WO | claimed |
| EP-4676430-A1 | HYDROXY ACIDS FOR SCALP AND HAIR IN SULFATE FREE PERSONAL CARE COMPOSITIONS | The Procter & Gamble Company (US) | 2026-01-14 | — | — | EP | disclosed |
| WO-2024187061-A1 | HYDROXY ACIDS FOR SCALP AND HAIR IN SULFATE FREE PERSONAL CARE COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2024-09-12 | — | — | WO | disclosed |
| US-20240299275-A1 | HYDROXY ACIDS FOR SCALP AND HAIR IN SULFATE FREE PERSONAL CARE COMPOSITIONS | THE PROCTER & GAMBLE COMPANY | 2024-09-12 | — | — | US | disclosed |
| WO-2017095445-A1 | CLEANSING BARS WITH TAURINE | COLGATE-PALMOLIVE COMPANY (US) | 2017-06-08 | — | — | WO | disclosed |
| WO-2016106071-A1 | ORAL CARE COMPOSITION | COLGATE-PALMOLIVE COMPANY (US) | 2016-06-30 | — | — | WO | disclosed |
| WO-2016089422-A1 | CLEANSING BARS WITH TAURINE | COLGATE-PALMOLIVE COMPANY (US) | 2016-06-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240299275-A1 | HYDROXY ACIDS FOR SCALP AND HAIR IN SULFATE FREE PERSONAL CARE COMPOSITIONS | HAO2, SCO2, POLR1C | LMNA 3460/4885BLM 2698/4885SLC6A6 151/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.